MEDICAL INNOVATIONS INC /DE/

Certification of termination of registration of a class of securities (Section 12(g))

Definitive Proxy Statement

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Registration statement under Securities Act of 1933 (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

Registration statement under Securities Act of 1933 (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Current report pursuant to Section 13 or 15(d) (amendment)

Registration statement under Securities Act of 1933 (amendment)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Current report pursuant to Section 13 or 15(d) (amendment)

Current report pursuant to Section 13 or 15(d)

No description available

General form for quarterly reports under Section 13 or 15(d)